A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERD

Summary

The purpose of this study is to evaluate the diagnostic value of tegoprazan for GERD. Patients experiencing typical GERD symptoms, such as heartburn and acid regurgitation, will take either tegoprazan or a placebo once daily for 1 week. Investigators will compare the short-term symptom improvement between the two groups to determine if an early response to tegoprazan can help diagnose GERD.

Timeline

Start

2026-09-01

Primary completion

2028-07-31

Completion

2028-07-31

Drugs

Indications